Prime Medicine Inc
(PRME)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRME | AZN | AMGN | GILD | BMY |
| Company | Prime Medicine Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.42 | 200.08 | 365.14 | 148.90 | 60.60 |
| High | 3.46 | 203.44 | 368.51 | 156.97 | 61.08 |
| Low | 3.28 | 199.19 | 361.00 | 147.38 | 59.66 |
| Latest | 3.39 | 202.19 | 365.65 | 155.56 | 60.81 |
| Change | -0.03 | +8.79 | +1.00 | +8.33 | -0.05 |
| % Change | -0.88% | +4.54% | +0.27% | +5.66% | -0.08% |
| Volume | 928,937 | 1,579,846 | 932,849 | 5,546,385 | 3,335,848 |
| 20-Day Average Volume | 3,009,538 | 4,574,079 | 3,098,323 | 8,339,062 | 13,251,413 |
| Previous Close | 3.42 | 193.40 | 364.65 | 147.23 | 60.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.90 | 188.04 | 349.66 | 139.02 | 56.75 |
| 20-Day Raw Stochastic | 10.74% | 99.39% | 71.74% | 99.71% | 87.30% |
| 20-Day Relative Strength | 42.74 | 63.87 | 60.83 | 73.65 | 68.65 |
| Weighted Alpha | -22.67 | +46.14 | +32.72 | +62.27 | +25.02 |
| Today's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 24% Buy | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.02% since 02/04/26 | +8.03% since 02/04/26 | +0.27% since 02/04/26 | +7.21% since 02/04/26 | +5.81% since 02/04/26 |
| Low | 3.21 on 02/05/26 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 145.87 on 02/05/26 | 58.00 on 02/05/26 |
| High | 3.64 on 02/10/26 | 202.66 on 02/11/26 | 385.12 on 02/06/26 | 156.88 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -14.47% since 01/09/26 | +6.98% since 01/09/26 | +12.60% since 01/09/26 | +29.46% since 01/09/26 | +9.15% since 01/09/26 |
| Low | 3.21 on 02/05/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 4.70 on 01/22/26 | 202.66 on 02/11/26 | 385.12 on 02/06/26 | 156.88 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -14.03% since 11/11/25 | +13.65% since 11/11/25 | +8.49% since 11/11/25 | +27.92% since 11/11/25 | +25.14% since 11/11/25 |
| Low | 3.17 on 11/14/25 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 4.70 on 01/22/26 | 202.66 on 02/11/26 | 385.12 on 02/06/26 | 156.88 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -3.99% since 08/11/25 | +36.70% since 08/11/25 | +28.80% since 08/11/25 | +30.14% since 08/11/25 | +32.75% since 08/11/25 |
| Low | 3.08 on 08/20/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 6.94 on 10/06/25 | 202.66 on 02/11/26 | 385.12 on 02/06/26 | 156.88 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 617,348 | 299,945,568 | 196,357,104 | 182,665,312 | 123,895,928 |
| Shares Outstanding, K | 180,511 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 2,980,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -195,880,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,230,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -50,580,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 2.70 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 11/07/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/27/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | 09/10/19 | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 17.20 | 18.52 | 9.88 |